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Abstract: The multidrug resistance (MDR) proteins that belong to the ATP-binding cassette superfamily such as P-
glycoprotein (P-gp) and MRP1, are present in a majority of human tumors and constitute an important cause of therapeu-
tic failure. Selective inhibitors of the MDR-efflux proteins may improve the effectiveness of cancer chemotherapy. Their 
mechanism of action was believed to be a competition between resistance modifiers and drugs for the same binding site of 
P-gp. In our previous work we studied modulation of MDR in cancer cells expressing P-gp or MRP1 by selected caro-
tenoids, flavonoids and extracts from medically important Chinese plants. Capsanthin and capsorubin, carotenoids iso-
lated from paprika, were identified as potent P-gp inhibitors, while lycopene, lutein, antheraxanthin and violaxanthin in-
duced moderate effects. Among flavonoids, effective modulators were rotenone, chrysin, phloretin and sakuranetin. Some 
chloroform extracts of Chinese herbs were also found to inhibit MDR efflux pumps. The effects of the modulators on P-
gp activity were studied by measuring rhodamine 123 uptake in several cancer cells such as the human MDR1 gene-
transfected mouse lymphoma cells (L1210) and human breast cancer cells MDA-MB-231 expressing the MRP1 pump 
(HTB26). Additionally, the ability to alter biophysical properties of lipid bilayers by selected carotenoids was studied by 
differential scanning calorimetry. The antiproliferative effects as well as the MDR reversal activity of the studied com-
pounds, applied in combination with anticancer drugs, were also discussed.  
Keywords: Carotenoids, Flavonoids, Human breast- and colon cancer, Mouse lymphoma cells transfected with human MDR1 
gene, Multidrug resistance (MDR), Resistance modifiers, Synergistic interactions, Traditional Chinese medicinal plants.  
INTRODUCTION 
 The discovery of chemotherapeutic agents from plant 
extracts led to the identification of new chemotherapeutic 
agents or to the isolation of compounds that enhance the 
anti-tumour activity of chemotherapeutic drugs by inhibiting 
multidrug resistance (MDR) of cancer cells. Extracts from 
paprika fruits contain many compounds such as carotenoids, 
flavonoids, isoflavones and xanthenes, active against ABC 
transporters. The inhibition of ABC transporters, responsible 
for MDR of cancer cells, is an important effect of the plant-
isolated compounds because efflux inhibitors applied in 
combination with anticancer drugs may reverse the resis-
tance of various types of tumor cells [1]. 
 MDR cancer cells are resistant to many anticancer drugs 
with different chemical structures and mechanisms of action. 
In cancer patients who do not respond to chemotherapy, 
MDR is usually mediated by the over-expression of various 
ATP-dependent efflux pumps displaying a broad substrate 
specificity, such as P-glycoprotein (P-gp), multidrug resis-
tance-associated protein 1 (MRP1) and breast cancer resis-
tance protein (BCRP) [2]. Expression of ABC transmem-
brane pumps leads to lowering of the intracellular  
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concentration of drugs, enabling tumor cells to survive de-
spite chemotherapeutic treatment. MDR inhibitors may 
block or slow down the pumps therefore the chemothera-
peutic drugs could remain longer inside the cells. Many other 
molecular mechanisms of drug resistance also exist, for ex-
ample the increased repair of chemotherapy-induced DNA 
damage [3].  
 Considering the growing need to identify MDR revertant 
agents with high potency and low toxicity, we studied the 
ability of natural products to counter drug resistance. In our 
systematic studies, extracts of green, yellow, red and black 
paprika fruits, one of the most popular vegetables, were stud-
ied and the most effective inhibitors of ABC transporters 
were subsequently identified.  
 Six different fractions extracted from green paprika with 
hexane, acetone and methanol were identified as containing 
MDR inhibitors [4]. A similar extraction procedure of red 
paprika fruits yielded altogether twelve fractions that exerted 
resistance reversal effect [5]. In case of black paprika, thir-
teen effective fractions were found [6]. Based on these stud-
ies, we supposed that some kinds of pigments present in 
green [4], black [6,7] and red paprika [5,8] could be respon-
sible for the MDR reversal effects. 
 The inhibition of MDR transporters by modulators can be 
exerted in three different ways: i) by competitive binding at 
the same site as the substrates (competitive inhibition); ii) by 
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allosteric modification of the active conformation of P-gp 
through a site far from the substrate binding site (non-
competitive inhibition), iii) by modulation of the membrane 
lipid bilayer in which P-gp is embedded. Resistance modifi-
ers may also bind to the extra-membrane domains of P-gp: 
iv) cytoplasmic, ATP-binding sites are sensitive to certain 
flavonoids, and v) the polylactosamine moiety, located on 
the first loop of extra-cellular domain may bind tomato lectin 
[9].  
 However, a therapeutic effect of carotenoids was only 
observed in the precancerous state and in  promyelocytic 
leukemia [10]. The reduced risk of developing ageing-related 
diseases was ascribed to a beneficial effect of carotenoids, 
such as -carotene [11]. Indeed, the higher intake of 
carotenoid-containing food is associated with reduced risk of 
developing several chronic diseases, such as coronary heart 
disease, cancer and cataract [12]. In animal experiments, it 
was shown that a carrot-rich diet can reduce tumor incidence 
in rats and mice treated with carcinogenic chemicals [13]. 
Both - and -carotene showed significant antitumor activity 
in the two stage carcinogenesis model [14]. 
 Recently, carotene-containing paprika extracts were 
fractionated by Motohashi and coworkers. Some of the 
fractions could apparently reverse MDR of tumor cells [4]. 
Considering previous results and the contradictory findings 
obtained with saffron compounds on resistant cancer cells 
[1], it seemed promising to study the MDR reversal effects 
of selected carotenoids isolated from paprika and other 
vegetables. 
CAROTENOIDS 
 Literature data suggest the potential importance of caro-
tenoids as resistance modifiers in cancer chemotherapy [1]. 
Previously, our group isolated and identified several caro-
tenoids [1,4,15]. Taking into account the blocking effect of 
hexane and acetone fractions of paprika extracts on the ABC 
transporters, the effects of carotenoids on the drug accumu-
lation in cancer cells were worth studying [1].  
 A study on rhodamine 123 uptake in MDR1 gene-
transfected mouse lymphoma (L1210) cells allowed us to 
classify the studied carotenoids into three different groups 
based on their MDR reversal activity: inactive, moderately 
active, or very active (Table 1). The most effective carote-
noids were capsanthin, capsorubin and lycophyll. Viola-
xanthin, lycopene, lutein, zeaxanthin, antheraxanthin, - and 
-cryptoxanthines were moderately active, while - and -
carotene had no effect. Thus, effective P-gp modulators were 
identified among carotenoids isolated from different kinds of 
paprika. The differential sensitivity of cancer cells to the 
various carotenoids may be explained by the differences in 
their diffusion properties or distribution in membrane. 
 Rhodamine 123 accumulation in the presence of caro-
tenoids was also studied in human breast cancer HTB26 cells 
that do not contain P-gp but only MRP1 [1]. The rhodamine 
123 accumulation in these cells was not modified after caro-
tenoid treatment. The results indicated that some caro-
tenoids, that exerted MDR reversing effect in P-gp-expres-
sing mouse lymphoma cells, were not able to modify the 
drug accumulation in human breast cancer cells (data not 
shown). Interestingly, MDR reversing effects of carotenoids, 
tested in two different cell lines, were apparently related to 
some properties of their chemical structures.  
 The majority of carotenoids hydroxylated at the right 
cyclohexene ring (- and -end group) revealed moderate 
MDR reversing effect. Antheraxanthin, lutein and zeaxanthin 
are some examples (Fig. (1)).  
 The hydroxylation at the right cyclopentane ring (-end 
group), in addition to the hydroxylation at the left ring (-
end group in capsanthin; -end group in capsorubin) could 
be responsible for the very high resistance reversal effect of 
capsanthin and capsorubin (Fig. (2)). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Chemical structures of carotenoids which are “moderately active” MDR reversal agents. 
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Fig. (2). Chemical structures of carotenoids which are “very active” MDR reversal agents. 
 
Table 1. MDR Reversal Effects of Carotenoids in Human MDR1 Gene Transfected Mouse Lymphoma Cells (L1210) 
Compound Conc [μg/mL] FARa References 
Verapamilb 5 5.73 [1] 
  inactive  
-Carotene 20 0.56 [1] 
-Carotene 20 0.81 [1] 
 moderately active 
Lycopene 20 9.70 [1] 
-Cryptoxanthin 20 9.65 [1] 
-Cryptoxanthin 20 4.42 [1] 
Zeaxanthin 20 9.67 [1] 
Lutein 20 10.06 [1] 
Antheraxanthin 20 10.17 [1] 
Violaxanthin 20 5.97 [1] 
 very active 
Capsanthin 20 27.59 [1] 
Capsorubin 20 24.46 [1] 
Lycophyll 20 25.2 [1] 
a FAR (Fluorescence Activity Ratio): mean fluorescence ratio for treated/untreated samples. b Reference compound. 
 
 Further studies on rare types of carotenoids revealed 
other effective MDR modulators [15]. Mutatochrome and 
diepoxy--carotene were moderately active on MDR rever-
sal activity in the L5178 cell line (Table 2). Flavoxanthin 
plus chrysanthemaxanthin, (5R,8R)-capsochrome, (5R,8S)-
capsochrome, (5S,8S)-capsochrome, (5S,8R)-capsochrome, 
monoepoxy--carotene, (8’R)-luteoxanthin, (13Z)-lutein+ 
(13’Z)-lutein, (9Z)-zeaxanthin, and (9Z)-violaxanthin, dis-
playing extremely high fluorescence activity ratio, showed 
high P-gp inhibition activity. 15,15’-Dehydro-diepoxy--
carotene and mono-epoxy--carotene were ineffective. 
 A much lower inhibitory effect of the same carotenoids 
was found in MCF7/MDR1 cells [15]. All compounds were 
able to moderately increase rhodamine 123 accumulation, 
with exception of 15,15’-dehydro-diepoxy--carotene that 
was inactive (Table 2). The different sensitivities of  L5178 
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and MCF7/MDR1 cells to carotenoids suggested that P-gp 
was likely differentially expressed in these cell lines, in spite 
of the fact that the drug accumulation in the presence of 
verapamil was similar in both cell lines. We also supposed 
that the cellular membrane properties differed in the two cell 
lines explaining their different sensitivity to hydrophobic 
carotenoids. 
 In fact, carotenoids are extremely hydrophobic, and 
sensitive to oxidation or photooxidation, so that their investi-
gation is laborous and time-consuming [16-18]. Therefore, 
complexes of carotenoids with cyclomalto-oligosaccharides 
as water soluble micelles have been recommended as a 
convenient and inexpensive solubilizing technique [18,19].  
Since there are many studies suggesting that interactions of 
MDR modulators with the lipid bilayer of biological mem-
branes might play an important role in MDR reversal [20], 
the ability of selected carotenoids to alter biophysical proper-
ties of membranes was investigated by differential scanning 
calorimetry (DSC) on the dimyristoylphosphatidylcholine 
(DMPC) model (Table 3). DSC is a precise method to study 
the influence of chemical compounds on thermotropic prop-
erties of phospholipid bilayers.  
 All the studied compounds abolished the pretransition 
parameters of DMPC and reduced the temperature of main 
phospholipid phase transition when present in the model 
membrane at a drug:lipid ratio 0.04. The melting temperature 
reduction ranged from 0.5 °C for capsorubin and -carotene 
to 1.5 °C for the most active (9Z)-violaxanthin. Additionally, 
a carotenoid-induced broadening of calorimetric peaks was 
observed, being the smallest for -carotene and capsorubin 
and the biggest for (9Z)-violaxanthin and antheraxanthin. 
Such an effect indicated a reduction of transition cooperativ-
ity. Some compounds also diminished the transition en-
thalpy. The most pronounced effect was observed for (9Z)-
violaxanthin and capsanthin, a smaller effect for antheraxan-
thin and violaxanthin, while capsorubin and -carotene did 
not affect this parameter (Table 3). 
 All studied carotenoids were observed to reduce the tran-
sition temperature and to decrease transition cooperativity, 
while their influence on transition enthalpy was weaker. The 
obtained results are in accordance with previously published 
data for other carotenoids [21]. The changes of biophysical 
properties of model membranes exerted by carotenoids were, 
according to the empirical classification introduced by Jain 
and Wu [22], typical for modifiers that interacted mainly 
Table 2. MDR Reversal Effects of Rare Types of Carotenoids in Human MDR1 Gene Transfected Mouse Lymphoma Cells 
(L5178) and Human Breast Cancer Doxorubicin resistant Cells (MCF7/KCR) Expressing MDR1 Gene. 
Compound  FAR
a
  FAR
a
 References 
 Conc [μg/mL] L5178/MDR1 cell line Conc [μg/mL] MCF7/MDR1 cell line  
Verapamilb 10 15.70 5 11.9 [15] 
 inactive  
15,15`-Dehydro-diepoxy--carotene 40 0.58 40 0.62 [15] 
Monoepoxy--carotene 40 0.56 40 - [15] 
    
 moderately active  
Diepoxy--carotene 40 5.72 40 2.08 [15] 
Mutatochrome 40 7.47 40 - [15] 
 very active moderately active  
Flavoxanthin plus Chrysanthemaxanthin 40 30.27 40 - [15] 
(5R,8R)-Capsochrome 40 37.92 40 1.95 [15] 
(5R,8S)-Capsochrome 40 56.81 40 1.67 [15] 
(5S,8S)-Capsochrome 40 41.52 40 1.99 [15] 
(5S,8R)-Capsochrome 40 53.54 40 1.38 [15] 
Monoepoxy--carotene 40 37.59 40 2.37 [15] 
(8’R)-Luteoxanthin 40 61.81 40 1.9 [15] 
(13Z)+(13’Z)-Lutein 40 31.42 40 2.0 [15] 
(9Z)-Zeaxanthin 40 20.54 40 - [15] 
(9Z)-Violaxanthin 40 57.74 40 2.2 [15] 
a FAR (Fluorescence Activity Ratio): mean fluorescence ratio for treated/untreated samples. b Reference compound. 
Reversal of Multidrug Resitance by Natural Substances from Plants Current Topics in Medicinal Chemistry, 2010, Vol. 10, No. 17    1761 
with the hydrophobic/hydrophilic interface of the membrane 
and that penetrated only partially the hydrocarbon region. 
The following modes for carotenoid-membrane interactions 
were postulated: i) carotenoid molecule could span lipid bi-
layer with polar groups located at two opposite sides of the 
molecule anchored in two opposite polar zones of the bi-
layer; ii) carotenoid molecule (especially cis-isomer) could 
adopt a tilted conformation and their two polar groups would 
interact with polar region of the same leaflet of a membrane 
[21]. 
 The moderately effective MDR modulators (9Z)-
violaxanthin and antheraxanthin were the most active com-
pounds in changing main DMPC phase transition parame-
ters. Among the least membrane-perturbing compounds, -
carotene and capsorubin were identified (Table 3). -
Carotene was also found to be non-active in P-gp modula-
tion; in contrast capsorubin, was identified among the most 
active MDR modulators. The above findings suggested that 
the interaction of carotenoids with P-gp, was not influenced 
by the binding of these compounds with lipid membrane.  
 Additionally, the effect of combined treatment (selected 
carotenoids and doxorubicin) on resistant cancer cells was 
tested in order to check whether their MDR would be re-
duced [15]. The results were encouraging as concomitant use 
of the anticancer drug and carotenoids resulted in synergism 
of the antiproliferative action in both human MDR1 gene-
transfected mouse lymphoma L5178 and MCF7/MDR1 hu-
man breast cancer cell lines. 
Multiple Pharmacological Targets of Carotenoids 
 The wide variety of carotenoids can influence multiple 
targets. Antiproliferative effects of lycopene, a carotenoid 
from tomato, on various prostate cancer cells have been 
studied and potent antitumor properties were demonstrated 
[18]. Lycopene was then studied in vivo, in healthy subjects 
and in patients with cervical, breast, ovarian and colorectal 
cancer. The results indicated that high serum concentrations 
of carotenoid were associated with a decreased risk of recur-
rence [23]. The growth inhibition of MCF7 (mammary 
cancer) cells was accompanied by a slowing down of cell 
cycle progression through the G1-S phases via reduction of 
cycline-D1 [19]. It was found that lycopene inhibited the 
growth of MCF7 cells and endometrial cancer by interfering 
with insulin-like growth factor (IGF) signal transduction, due 
to a decrease in IGF-induced tyrosine phosphorylation of the 
insulin receptor [24,25]. These growth factors act on the 
oncogenes [26], affect the activity of apoptosis pathways 
[27] and protect against membrane damage. In addition to 
the discussed mechanism of actions, carotenoids exert immu-
nomodulatory effects through complex mechanisms, such as 
immune-stimulation, which may involve antioxidant and 
singlet oxygene quenching capacities of the carotenoids 
having nine or more conjugated double bonds [28]. 
 The dietary absorption and bioavailability of lutein and 
zeaxanthin were studied and epimeric isomers were found in 
the human serum [29]. It was suggested that a high intake of 
carotenoid-containing fruits and vegetables was associated 
with a reduced risk of lung cancer. Studies showed that -
carotene rather than -carotene might be responsible for this 
effect [30]. It was shown that numerous carotenoids exert an 
inhibitory action on free radical generation in leukocytes 
[31]. Some of the carotenoids, e.g. capsanthin, isolated from 
the fruits of red paprika Capsicum annum L. remarkably in-
hibited early tumour antigen expression of Epstein-Barr vi-
rus (EBV) after Tissue Polypeptide Antigen (TPA) induction 
[32]. This antitumour effect of paprika carotenoids was ob-
served both in vitro and in vivo. Data demonstrated that the 
increased consumption of carotenoids reduces the risk of 
cancers especially in the respiratory and digestive tracts [33]. 
A carotenoid-rich diet can suppress prostate cancer devel-
opment by inducing apoptotic cell death, a process in which 
the proteins Bcl-2 and Bax, members of the Bcl-2 family of 
apoptosis-associated proteins are involved [34]. Carotenoids 
are also capable of reducing cell cycle progression from G1 
to S phase induced by growth factors [35]. 
FLAVONOIDS 
 Flavonoids have been studied as MDR reverting agents 
in several tumor cell lines overexpressing MDR proteins. 
 The accumulation of rhodamine 123 in mouse lymphoma 
cells transfected with the human MDR1 gene and in human 
breast cancer cells expressing MRP1 (HTB26) was com-
Table 3. Influence of Selected Carotenoids on Transition Parameters of Dimyristoylphosphatidylcholine (DMPC). Drug:Lipid 
Molar Ratio was 0.04. Mean ± S.D. of Eight Experiments is Shown 
Compound Transition Temperature [°C] Transition Enthalpy [kJ/mol] Peak Half-Height Width (T1/2) [°C] 
DMPC 23.10 ± 0.09 26.0 0.44 ± 0.02 
DMPC +    
Capsanthin 21.85 ± 0.09 13.59 ± 2.38 0.82 ± 0.05 
Capsorubin 22.48 ± 0.09 23.52 ± 0.75 0.74 ± 0.07 
Antheraxanthin 21.79 ± 0.07 16.26 ± 1.61 1.38 ± 0.11 
Violaxanthin 21.88 ± 0.04 16.44 ± 1.85 0.91 ± 0.05 
(9Z)-Violaxanthin 21.62 ± 0.16 13.21 ± 1.19 1.10 ± 0.17 
-Carotene 22.49 ± 0.03 25.03 ± 2.19 0.67 ± 0.04 
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pared in the presence and absence of naturally occurring 
plant-derived isoflavonoids (Fig. (3)), taking into account the 
results of our former studies [36]. Amorphigenin and for-
mononetin proved to be the most effective MDR reversal 
agents in transfected mouse lymphoma cell line. Afrormosin, 
(+)-12a-hydroxyamorphigenin and 6a,12a-dehydroamor-
phigenin were moderately effective in P-gp expressing 
mouse lymphoma cells (Table 4). 
 The same flavonoids were tested in HTB26 cells by mea-
suring the fluorescent accumulation of 2',7'-bis'(carboxy-
ethyl)-5-(6')-carboxyfluorescein (BCECF), a specific MRP1 
substrate. MRP1 expression and transport activity were ana-
lysed by flow cytometry [15], although the sensitivity of this 
method is lower than rhodamine 123 exclusion test. All 
tested compounds moderately increased BCECF accumula-
tion in HTB26 cells (Table 4).  
 The ability of another set of flavonoids to inhibit MDR-
related efflux pumps has also been tested [36] in different 
cell lines. This set included dihydroflavonols (dihydrofisetin, 
dihydrorobinetin, dihydroquercetin and sakuranin), flavonols 
(kaempferol, robinetin and robinin), flavanons (naringin, 
neohesperidin and sakuranetin), dihydrochalcones (phloretin 
and phloridzin), one flavon (chrysin), one rotenoid (rote-
none) and flavan-3-ols (catechin, epigallocatechin) (Fig. (4)). 
 In P-gp expressing mouse lymphoma cells, rotenone, 
chrysin, and epigallocatechin increased rhodamine 123 ac-
cumulation and displayed a dose-dependent increase in the 
fluorescence activity ratio (Table 5). These flavonoids were 
better enhancers of fluorescent probe accumulation than the 
reference compound verapamil. Catechin, neohesperidin, 
naringin, robinin, phloretin and sakuranetin displayed mod-
erate effects, while dihydroquercetin, dihydrofisetin, dihy-
drorobinetin, phloridzin, kaempferol, sakuranin, robinetin 
and dihydrorobinetin had no effect. 
 The effects of flavonoids on the MRP1 pump were tested 
by measuring BCECF accumulation in HTB26 cells [36]. 
Chrysin, robinin, kaempferol, dihydroquercetin, dihydroro-
binetin, dihydrofisetin and epigallocatechin displayed the 
same effect as indomethacin, viz. increasing BCECF accu-
mulation. On the other hand, neohesperidin, naringin, 
phloretin, phloridzin, robinetin, dihydrofisetin, rotenone, 
catechin, sakuranin and sakuranetin showed a poor activity.  
 The effect of different flavonoids on rhodamine 123 ac-
cumulation in P-gp-expressing human colon cancer cells 
(Colo320) was also studied [36]. Rotenone was the most 
effective inhibitor of the P-gp efflux pump. Sakuranetin, 
dihydrorobinetin, phloridzin, naringin, neohesperidin, cate-
chin, robinin, dihydrophysetin and epigallocatechin had only 
moderate effects, while robinetin, kaempferol, dihydroquer-
cetin and sakuranin displayed a poor effect (Table 5). 
 Finally, an enhanced antiproliferative activity of flavon-
oids in combination with epirubicin was observed in both P-
gp and MRP1 expressing cells [36]. When such a combina-
tory treatment was applied to drug-resistant mouse lym-
phoma cells and antiproliferative effects were measured, a 
synergistic effect was observed in the case of chrysin and 
amorphigenin and an additive one in the case of rotenone. In 
HTB26 cells, formononetin and kaempferol displayed syner-
gistic antiproliferative effects when they were combined 
with epirubicin, while afrormosin and robinin affected pro-
liferation in an additive way [36]. 
 The drug accumulation studies have proven that P-gp 
inhibition by flavonoids is higher than MRP1 inhibition. 
However, in combination with epirubicin some compounds 
were more effective than expected in the MRP1-expressing 
human breast cancer cell line. P-gp and MRP1 may not be 
equally sensitive to inhibition by flavonoids and the antipro-
liferative effects of simultaneously applied anticancer drugs 
could be different in cell lines expressing different efflux 
pumps. One of the differences between the two efflux sys-
tems is that P-gp binds the unmodified transported drug, 
whereas MRP1 predominantly pumps out drugs conjugated 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). Isoflavonoids which are MDR reverting agents. 
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Table 4. MDR Reversal Effects of Isoflavonoids in Human MDR1 Gene Transfected Mouse Lymphoma Cells and HTB26/MRP1 
Cells 
Compound Conc [μg/mL] FARa References 
  Rhodamine 123 accumulation BCECF accumulation  
  Mouse lynphoma/ MDR1 cells HTB26/MRP1 cells  
Verapamilb 5 17.1  [36] 
Indomethacinc 10  2.4 [36] 
Formononetin 40 18.3 1.5 [36] 
Amorphigenin 40 46.4 1.0 [36] 
Afrormosin 40 3.1 1.4 [36] 
6a,12a-Dehydroamorphigenin 40 3.0 1.2 [36] 
(+)-12a-Hydroxyamorphigenin 40 2.8 1.1 [36] 
a FAR (Fluorescence Activity Ratio): mean fluorescence ratio for treated/untreated samples. b Reference compound of mouse lymphoma/MDR1 cells. . c Reference compound of 
HTB26/MRP1 cells. 
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Fig. (4). Some flavonoid subclasses which are MDR reverting agents. 
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contradictory results have been reported for the MDR-
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modulating activity of the flavonoids kaempferol and quer-
cetin, which were previously found to stimulate P-gp-
mediated efflux of doxorubicin in a resistant colon cancer 
cell line [41]. In our experiments, kaempferol was ineffective 
whereas chrysin showed a significant inhibitory effect [36]. 
Rotenoid derivatives, amorphigenin and rotenone, had sig-
nificant MDR-modulating activity. The concentrations of the 
test compounds were crucial. For example, at low concentra-
tions quercetin activated the activity of P-gp whereas at high 
concentrations it inhibited this pump [36]. A similar biphasic 
effect has been observed for kaempferol. The effects of vari-
ous flavonoids on drug accumulation were also studied in 
resistant human colon cancer cells and their drug sensitive 
counterparts [36]. In these cell lines,  rotenone was an effec-
tive inhibitor of drug efflux whereas phloridzin, catechin, 
neohesperidin, naringin, and robinin influenced rhodamine 
123 accumulation slightly. 
 The main conclusion drawn from our studies was that 
flavonoids and isoflavonoids differentially affected P-gp- 
and MRP1-mediated drug resistance and that the chemical 
structure of modulators was of great importance. This was in 
agreement with other studies. P-gp was inhibited by flavon-
oids such as formononetin, amorphigenin, rotenone and 
chrysin [40,41]. MRP1-mediated carboxyfluorescein efflux 
was reduced by afrormosin, formononetin, amorphigenin, 
rotenone, chrysin, robinin, kaempferol and epigallocatechin 
[38,39]. The effect was probably an inhibition of ATPase 
activity [38,42]. In addition, some flavonols stimulated the 
efflux of carcinogens in P-gp-expressing breast cancer cells 
[43]. 
 By comparison of the fluorescence activity ratios and 
chemical structures of the studied compounds, a certain cor-
relation between MDR modulating activity and physico-
chemical parameters could be found. The majority of caro-
tenoids may have a special binding site on P-gp, in contrast 
flavonoids are likely to posses multiple targets, whereas only 
the ATP binding site contributes to P-gp inhibition. 
EXTRACTS FROM CHINESE MEDICINAL HERBS  
 Traditional Chinese Medicine (TCM) is a complete 
medical system that has been used to diagnose, treat, and 
prevent illnesses for more than 2,000 years. The principal Fu 
Zhen herbs (astragalus, ligustrum, ginseng, codonopsis, 
Table 5. MDR Reversal Effect of Flavonoids in Human MDR1 Gene Transfected Mouse Lymphoma cells, Colo320/MDR1 Cells 
and HTB26/MRP1 Cells 
Compound Conc [μg/mL] FARa References 
  Rhodamine 123 accumulation BCECF accumulation  
  Mouse lymphoma/MDR1 cells COLO320/MDR1 cells HTB26/MRP1 cells  
Verapamil
b
 5 8.9 21.6  [36] 
Indomethacinc 10   1.3 [36] 
Rotenone 40 28.6 40.04 0.3 [36] 
Catechin 40 2.9 1.57 0.6 [36] 
Neohesperidin 40 2.8 1.55 0.9 [36] 
Naringin 40 2.3 1.18 0.8 [36] 
Chrysin 40 14.6  1.2 [36] 
Robinin 40 1.5 1.18 1.6 [36] 
Phloretin 40 4.9  1.0 [36] 
Phloridzin 40 0.6 2.81 0.9 [36] 
Robinetin 40 0.7 0.83 0.9 [36] 
Dihydrorobinetin 40 0.7 1.48 1.1 [36] 
Kaempferol 40 0.8 0.81 1.3 [36] 
Dihydrofisetin 40 0.5 1.21 1.0 [36] 
Dihydroquercetin 40 0.6 0.91 1.3 [36] 
Sakuranin 40 0.8 0.52 0.7 [36] 
Sakuranetin 40 2.4 5.2 0.8 [36] 
Epigallocatechin 40 36.1 3.80 1.3 [36] 
a FAR (Fluorescence Activity Ratio): mean fluorescence ratio for treated/untreated samples. b Reference compound of mouse lymphoma/MDR1 cells. . c Reference compound of 
HTB26/MRP1 cells. 
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atractylodes, and ganoderma) are believed to strengthen the 
body's nonspecific immunity and to increase the functions of 
T-cells. Herbal antitoxin therapies, also regularly used, con-
tain many herbs that have been found to inhibit tumor 
growth by a variety of mechanisms. Kelp and pokeroot (Phy-
tolacca americana) are among the herbs used to treat tumors 
in Chinese herbal therapy. The most highly praised blood 
tonic in the East, Tang kuei (Angelica sinensis), has been 
used clinically in China to treat cancer of the esophagus and 
liver with good results. There are plenty examples of the 
effects of the recommended plant extracts [44]. In recent 
years there has been a trend to integrate TCM treatment with 
standard Western medicine in an attempt to further optimize 
treatment outcome, minimize the side effects of surgery, 
radiation and chemotherapy, increase immune function and 
improve survival [45]. 
 Certain compounds extracted from Chinese herbal medi-
cines have been reported to be capable of reversing MDR in 
tumor cells [46]. We have studied the anti-MDR properties 
of Chinese herbal extracts obtained from twelve selected 
medicinal plants, using different solvents such as methanol, 
chloroform, ethyl acetate and water [47]. The following rep-
resentative plant species were selected on the basis of their 
possible antitumor and imunomodulation activities as 
described in TCM: Astragalus membranaceus var. mong-
holicus, Glehnia littoralis, Asparagus cochinchinensis, 
Ligustrum lucidum, Aconitum carmichaeli, Astragalus mem-
branaceus, Selaginella doederleinii, Atractylodes macro-
cephala, Poria cocos, Asarum heteropoides var. mand-
shuricum, Paris polyphylla var. chinensis. 
 When the four types of extracts (methanol, chloroform, 
ethyl-acetate and water) were studied in resistant mouse 
lymphoma cells in a search for putative MDR modulators, 
chloroform extracts demonstrated the highest P-gp-inhibitory 
activity [47]. The most effective resistance modifiers were 
found in chloroform extracts from Ligustrum lucidum, Se-
laginella doederleinii, Atractylodes macrocephala, and Asa-
rum heteropoides var. mandshuricum (Table 6). Some ex-
tracts exhibited very high ID50 values (> 100 μg/mL) sug-
gesting that they could contain compounds that were sub-
strates of P-gp. The aqueous extracts were practically inef-
fective (data not shown).  
 The ability of Chinese plant extracts to reverse multidrug 
resistance in P-gp expressing mouse lymphoma cells in 
combination with doxorubicin has been also studied [47]. 
Asarum heteropoides var. mandshuricum revealed high anti-
MDR activity not only when applied alone. When it was 
combined with doxorubicin, a synergistic effect was ob-
served. The other MDR-reversal extract (from Selaginella 
doederleinii) applied together with the anticancer drug dis-
played only an additive effect [47]. Previous studies have 
shown that polysaccharides from Astragalus membranaceus 
are capable of inhibiting tumor development, decreasing the 
toxic effect of chemotherapy, enhancing the immune func-
tion of the organism and improving the quality of life in pa-
tients with malignant tumors [48]. Moreover, it has been 
reported that injection of Astragalus membranaceus extract 
can enhance the antitumor metastatic action of dentritic cells, 
and can effectively promote the immune response of the tu-
mor-bearing host; it therefore exerts an inhibitory effect on 
cancer metastasis in vivo [49]. Atractyloides macrocephala 
has long been used to induce cancer remission [50]. 
 The human cytomegalovirus (CMV) preferentially in-
fects tumor tissues and the accumulated CMV immediate 
Table 6. MDR Reversal Effect of Methanol, Chloroform and Ethyl-Acetate Extracts of CHINESE Plants (20 μg/mL of Each Ex-
tract was Used) in MDR1 Gene-Transfected Mouse Lymphoma Cells 
Chinese plants FAR
a
 Reference 
 Extracts  
 Methanol Chloroform Ethyl-acetate  
root of Astragalus membranaceus var. mongholicus 1.48 2.24 1.26 [47] 
root of Glehnia littoralis 1.03 1.27 1.18 [47] 
tuber of Asparagus cochinchinensis 1.09 1.78 0.94 [47] 
fruit of Ligustrum lucidum 1.85 3.54 1.07 [47] 
tuber of Aconitum carmichaeli 1.01 2.19 10.35 [47] 
Massa medicata fermentata Astragalus membranaceus 1.01 1.57 0.94 [47] 
herb of Selaginella doederleinii 2.17 16.69 5.10 [47] 
rhizome of Atractylodes macrocephala 1.66 3.93 3.54 [47] 
sclerotium of Poria cocos 1.69 1.51 0.95 [47] 
entire plant of Asarum heteropoides var. mandshuricum 1.12 27.15 1.28 [47] 
root of Paris polyphylla var. chinensis 1.31 1.51 1.59 [47] 
root of Astragalus membranaceus 1.19 1.82 1.13 [47] 
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early antigen (IE) may lead to tumor promotion and progres-
sion [51,52]. The development of strategies to inhibit the 
expression and/or function of human IE antigen is an impor-
tant goal to prevent and treat certain forms of cancer associ-
ated with human CMV. Human CMV was used in a modi-
fied in vitro model [53,54] for the screening of selected Chi-
nese plant extracts for antitumor-promoting activity [47]. 
The concentrations of test extracts greatly influenced the 
results of the experiments. A low extract concentration, for 
example, increased the IE antigen expression of CMV, 
whereas a high concentration decreased it. Ukiya et al. [55] 
demonstrated that certain lanostane-type triterpenoids from 
Poria cocos may inhibit tumor promotion and progression, 
and markedly suppress the Epstein-Barr virus (EBV) early 
antigen activation. This finding is in contrast with our results 
[47], where chloroform extracts of P. cocos did not modify 
the IE antigen expression of CMV in human lung cancer 
(A459) cells. 
 The integration of Western and oriental medicinal know-
ledge will lead to optimization of the therapeutic uses of 
Chinese medicinal plants in the foreseeable future. These 
plants contain many compounds responsible for various bio-
logical effects, and it is therefore important to know what 
types of compounds exert anticancer or antitumor-promoting 
activity. 
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